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A B S T R A C T
Benzoquinone (BQ) and benzoquinone derivatives (BQD) are used in the production of dyes and
cosmetics. While BQ, an extreme skin sensitizer, is an electrophile known to covalently modify proteins
via Michael Addition (MA) reaction whilst halogen substituted BQD undergo nucleophilic vinylic
substitution (SNV) mechanism onto amine and thiol moieties on proteins, the allergenic effects of adding
substituents on BQ have not been reported. The effects of inserting substituents on the BQ ring has not
been studied in animal assays. However, mandated reduction/elimination of animals used in cosmetics
testing in Europe has led to an increased need for alternatives for the prediction of skin sensitization
potential. Electron withdrawing and electron donating substituents on BQ were assessed for effects on BQ
reactivity toward nitrobenzene thiol (NBT). The NBT binding studies demonstrated that addition of EWG
to BQ as exemplified by the chlorine substituted BQDs increased reactivity while addition of EDG as in the
methyl substituted BQDs reduced reactivity. BQ and BQD skin allerginicity was evaluated in the murine
local lymph node assay (LLNA). BQD with electron withdrawing groups had the highest chemical potency
followed by unsubstituted BQ and the least potent were the BQD with electron donating groups. The BQD
results demonstrate the impact of inductive effects on both BQ reactivity and allergenicity, and suggest
the potential utility of chemical reactivity data for electrophilic allergen identification and potency
ranking.
ã 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Allergic contact dermatitis (ACD) is a prevalent occupational
disease caused by a wide range of chemicals (Payne and Walsh,
1994; Roberts et al., 2011). ACD which is estimated to affect 1–4%
(Smith and Hotchkiss, 2001) of the general world-wide population,
accounts for 30–>50% of occupational skin disorders depending on
the industry. Over 13 million workers in the US are believed to be at
risk from exposure to potential skin sensitizers and the level of
compensation due to occupational contact dermatitis has been
estimated to be greater than $1 billion/yr (Mathias and Morrison,
1988). ACD is also a significant health hazard of concern to
developers of cosmetic, personal care, chemical, pharmaceutical,
and medical device products (Mckim et al., 2010; Roberts and
Aptula, 2008).
Existing animal based assays such as the murine local lymph
node assay (LLNA) (Basketter et al., 2000), which is based on the
proliferation of lymph node cells in the induction phase or the
mouse ear swelling test (MEST) (Gad, 1994) and the guinea pig
maximization test (GPMT) (GPMT, 2002) which are based on the
observation of the allergic responses in the elicitation phase of ACD
are widely used to identify skin sensitizing chemicals and to
measure the relative sensitization potential of contact allergens.
Predictive animal tests such as the LLNA that have the capacity to
identify sensitizers before they are placed on the market have been
highly successful (Basketter and Maxwell, 2007). However, the
mandated reduction/elimination of animals testing for cosmetics
use in Europe has led to an increased need for alternatives methods
for prediction of skin sensitization potential (Roberts et al., 2007).
Most researchers moved to the LLNA due to its animal welfare
Abbreviations: ACD, Allergic contact dermatitis; BQ, p- benzoquinone; BQD,
benzoquinone derivatives; CBQ, chlorobenzoquinone; 2,5-DCBQ, 2,5-dichloroben-
zoquinone; EDG, electron donating groups; EWG, electron withdrawing groups;
ICD, irritant contact dermatitis; LLNA, local lymph node assay; EC3, estimated
concentration that produces a 3 fold increase in lymph node cell proliferation over
the vehicle control; 2-MBQ, 2 methyl- benzoquinone; MA, Michael addition; NBT,
nitrobenzenethiol; SI, stimulation index,; 2-tBBQ, 2-tertbutyl benzoquinone; SNV,
nucleophilic vinylic substitution.
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benefits while efforts to develop robust alternative non-animal test
methods still continue. For example, a published dataset consisting
of quantitative test results for compounds tested in the LLNA is
being used to develop and evaluate (validating or invalidating)
alternative approaches (Roberts et al., 2011).
Hundreds of chemicals, belonging to different reaction mecha-
nistic domains, have been shown to possess the ability to induce
skin sensitization. One group of these chemicals is benzoquinone
(BQ) and the benzoquinone derivatives (BQD). While BQ and BQD
are used in the production of dyes (Boga et al., 2013; Shimada et al.,
2015) they can be reduced to hydroquinones which are used in
cosmetics (Dlova et al., 2015; Matsubayashi et al., 2002; Shin and
Park, 2014; Uddin et al., 2011), leading to potential skin exposure.
BQ is an extreme skin sensitizer EC3 = 0.013% (EC3 is the estimated
concentration that produces a 3 fold increase in lymph node cell
proliferation over the vehicle control) (Roberts and Aptula, 2009)
but the effects of inserting substituents on the BQ ring have not
been studied in animal assays. BQ and BQD are known to covalently
modify proteins via the Michael addition (MA) reaction and/or
through nucleophilic vinylic substitution (SNV), depending on
whether it is attached to either electron donating groups (EDGs) or
electron withdrawing groups (EWGs) that are good leaving groups
(Mbiya et al., 2012).
The seven BQD test chemicals studied with expected sites of
nucleophilic attack on the ring are shown in Figure 1. The reported
(Mbiya et al., 2012) reactivity constants (ka) for BQ and BQD were
used to predict the LLNA EC3 values for the BQD after which LLNA
studies were then performed for BQ and BQD to determine the EC3
values. LLNA studies also served to test the predictive power of the
reactivity data thus evaluating the potential utility of the reactivity
approach as an alternative method for skin sensitization testing.
2. Experimental
2.1. Chemicals
100 mM phosphate buffer (pH 7.4) was made using mono-
sodium phosphate and disodium phosphate, acetic acid, sodium
acetate, acetonitrile (ACN), 4-nitrobenzenethiol (NBT). All test
chemicals were purchased from Sigma Chemical Co. (St. Louis, MO)
unless otherwise stated.
3. Methods
3.1. Approach for QSAR analysis
The ka values reported in Mbiya et al., (2012), where BQ and
BQD were reacted with NBT, were adopted. The structures of test
compounds are given in Fig. 1 and the arrows indicate the reaction
sites. The log P values were calculated from structure using
ADMET1 (MedChem-Designer) Version: 2.0 software (Dearden,
2007).
3.2. Local lymph node assay
Female BALB/c mice were purchased from Taconic (Hudson, NY,
USA). Animals were 6–8 weeks old upon arrival and allowed to
acclimate for a minimum of 10 days. Animals were housed in the
Association for Assessment and Accreditation of Laboratory
Animal Care International-accredited animal facility at National
Institute for Occupational Safety and Health (NIOSH), Morgan-
town, WV, USA. Animals were housed under controlled environ-
mental conditions in High Efficiency Particulate Act (HEPA)-
filtered ventilated polycarbonate cages on autoclaved hardwood
beta-chip bedding and provided Teklad 7913 food and autoclaved
tap water ad libitum. All animal procedures were reviewed and
approved by the NIOSH Animal Care and Use Committee.
The LLNA was performed according to the Interagency
Coordinating Committee on the Validation of Alternative Methods
(ICCVAM) standard method (Haneke et al., 2001) to determine the
allergenic potency of test chemicals. The LLNA test was conducted
in three independent blocks, each of which contained solvent
controls, assay of 2 BQD and BQ as the positive control. After
randomly grouping mice into groups (n = 4), mice were dosed with
25 mL/ear of a test chemical in acetone olive oil (AOO; 4:1). The
negative vehicle control group was dosed with AOO. The vehicle
and test chemicals were applied on the dorsum of both ears. Two
hundred mL of 20 mCi 3H-thymidine in 0.01 M phosphate buffered
Fig. 1. BQ and BQD test chemicals and their corresponding observed EC3 values. The arrows are the sites of nucleophilic attack.
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saline was injected into the tail vein on day 6, and after 5 h the mice
were euthanized via CO2 inhalation. Left and right draining
auricular lymph nodes were excised and pooled for each animal.
Single cell suspensions were made and following overnight protein
precipitation using 5% trichloroacetic acid (TCA), samples were
counted on a Packard Tri-Carb 2500TR (Meriden, CT) liquid
scintillation analyzer with background subtraction. Stimulation
indices (SI) were calculated by dividing the mean disintegrations
per minute (DPM) per test group by the mean DPM for the vehicle
control group. The EC3 (effective concentration inducing a 3-fold
increase in 3H-thymidine incorporation in the harvested lymph
node cells of treated animals compared to vehicle-treated animals)
was estimated by the benchmark approach, by fitting a nonlinear
regression model to the data of all individual animals.
3.3. Statistical analysis
3.3.1. LLNA
The structure of these experiments was a nested design. Mice
were randomly placed into treatment groups, which included
solvent control, positive control and hapten groups. Lymph node
cell proliferation was measured as described above. A sample size
of four per treatment group provides greater than 95% power to
find a change in lymphocyte proliferative activity of at least 50%,
based on a treatment variance of 20%, which was based on previous
studies. Analysis was performed using the Mixed Procedure on an
SAS platform to perform a hierarchical analysis of variance. Results
will be considered significant if p < 0.05. The values are given as
mean  SD. SigmaPlot (Version 12.0 Systat Software Inc.) was used
for statistical analysis and graphical presentation (Gurevitch,
1991).
4. Results
4.1. NBT-BQ/BQD reactions
Reaction rate constants of BQ and BQD toward NBT that were
previously determined (Mbiya et al., 2012), along with predicted
EC3 values derived from equations correlating electrophilic
allergen reactivity (to NBT) with pEC3, are shown in Table 1.
Reactivity of BQ and BQD toward NBT was used as a surrogate for
protein binding of the electrophiles in phosphate buffer at pH 7.4.
From the rate data determined empirically, the order of reactivity
toward NBT is 2,5-DCBQ > 2,6-DCBQ > 2-CBQ > BQ > 2-MBQ > 2-
tBBQ > 2,5-DMBQ. There was no observable relationship between
solubility (log P) and EC3 predicted by chemical reactivity across
the entire set of test chemicals.
4.1.1. Prediction of EC3 values from reactivity data
The ka values taken from Table 1 were used to predict
EC3 values using the linear equation A1 which was derived by
Chipinda et al., (2010) using a structurally diverse MA domain data
set where pEC3 is obtained by dividing the molecular weight (Mwt)
of the chemical by EC3 value and calculating the log (A2). The
results were compared with EC3 values obtained from the LLNA
performed for these BQD.
pEC3 ¼ 0:81 logka þ 2:13 A1
pEC3 ¼ log Mwt
EC3
 
A2
The presence of the EDG on the BQ reduces the predicted LLNA
potency of BQ (predicted EC3; 0.002%) from an extreme sensitizer
to a strong sensitizer (2,5-DMBQ; predicted EC3 = 1.28%). Addition
of an EWG increased the reactivity and thus the relative predicted
potency rating of BQ (Table 1).
4.2. LLNA: skin sensitization assessment
The LLNA was performed for BQ to derive a more accurate
EC3 estimate rather than use the literature EC3 value for BQ which
was extrapolated from doses that produced high stimulation
indexes (SI) well above the three-fold threshold (Chipinda et al.,
2010). BQ was then used as the positive control for all subsequent
LLNA studies. Fig. 2a and b show the doses of each BQD and the
stimulation indexes. The LLNA EC3 values estimation was
conducted following log transformation of the SI data. BQ and
chlorine substituted BQ allergenic potency increased in the
following order: BQ (EC3 = 0.043%) < CBQ (EC3 = 0.039%) < 2,6-
DCBQ (EC3 = 0.028%) < 2,5-DCBQ (EC3 = 0.013%) in agreement with
the trend predicted by rate constants (listed in Table 1). Methyl
substituted BQ EC3 values which ranged from <0.1% to 0.238%
were higher than those of chloro BQD. For 2-MBQ and 2,5-DMBQ
the LLNA EC3s predicted by reactivity were different from the
experimentally determined the EC3s. On the basis of reactivity
alone all the BQD, except 2,5-DMBQ, were predicted to be extreme
sensitizers. While reactivity data predicted 2,5-DMBQ to have an
18-fold higher EC3 than 2-MBQ, the experimental EC3 values of
these two electrophilic chemicals were similar to each other, but in
the reverse order than predicted. However, the 10% 2-MBQ dose
(SI = 31.6%) produced a statistically significant higher SI (P < 0.001)
than the 10% 2,5-DMBQ dose (SI = 11.4%) suggesting that it may
actually be a more potent allergen than 2,5-DMBQ as predicted
from the reactivity data (Fig. 2b). 2-tBBQ EC3 could not be
estimated using the LLNA due to systemic toxicity observed and
lack of dose-dependency of the lymph node cell proliferation in
dosed mice. In general, the predictive equation of Chipinda et al.,
(2010) was generated from data derived from multiple structurally
diverse chemicals with reaction rates which were lower than those
of BQ. This resulted in consistent overestimation of the potency of
the BQD series.
4.3. Correlation analysis of reactivity data with LLNA EC3 values
The pEC3 determined from LLNA SI values for the test chemicals
were plotted against log ka values to determine the relationship of
reactivity to chemical skin sensitization potency. A plot of
Table 1
Predicted EC3 values from reactivity data.
Chemical Mwt (g/mol) ka (s1) pEC3 Predicted EC3 (%)a LLNA derived EC3 (%) Log P
2,5-DCBQ 176.9 2.92  106 7.37 7.61 106 0.013 1.341
2-CBQ 142.5 2.17  105 6.45 4.82  105 0.039 0.980
2,6-DCBQ 176.9 1.60  106 7.16 1.24 105 0.028 1.338
BQ 108.1 1.66  103 4.74 1.97  103 0.043 0.497
2-MBQ 122.1 1.51 103 4.23 7.24 102 0.238 0.752
2-tBBQ 164.2 3.60  102 3.25 9.31 102 – 1.998
2,5-DMBQ 136.2 1.05 101 2.03 1.28 0.181 1.070
a Estimations of EC3 were performed using the regression equation pEC3 = 0.81 log ka + 2.13 as reported by Chipinda et al., (2010) where pEC3 = log (Mwt/EC3).
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pEC3 values for 6 test chemicals is shown in Fig. 3. A strong positive
correlation (R2 = 0.74) between potency in LLNA and reactivity was
observed as indicated by the following linear equation A3 (with
statistical parameters);
pEC3 ¼ 0:20 0:05ð ÞlogðkaÞ þ 0:18 0:33ð Þ A3
n = 6, R2 = 0.74, R2adj = 0.68, s = 0.27 and F = 11.6
It must be stated that due to the limited number of the test
chemicals used in this study conclusions concerning the potential
relationship between mechanism of chemical reactivity and
allergenic potency cannot be made from these results. R2 of
0.74 between the overlapping data of MA and SNV domains
suggests that reactivity rate has greater influence than chemical
mechanistic domain toward a chemical’s allergenic potency
(Mbiya et al., 2012).
5. Discussion
The BQ moiety common to all test chemicals within this series
was considered important to allow an accurate comparison of the
reactivity to NBT as well as allergenic potency in the LLNA, while
avoiding potential confounders that may arise from structural
Fig. 2. Murine local lymph node assay (LLNA) for BQ and BQD (a): BQ(0.043%), 2-ClBQ(0.039%), 2,5-DClBQ(0.013%) and 2,6-DCBQ(0.028%), (b): 2-MBQ(0.238%), 2,6-DMBQ
(0.181%) and tBBQ(–%). tBBQ produced clinical signs of systemic toxicity including weight loss, lethargy and ruffled fur that gave poor dose-dependent proliferative responses
and preventing a reliable EC3 determination. (*) the 10% dose SI for 2-MBQ is greater than 2,5-DMBQ (P < 0.001).
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differences. From the LLNA data and prediction of EC3 values using
rate constants, we observed that BQD with EWGs had the highest
chemical potency, followed by unsubstituted BQ, and the least
potent were the BQD with EDGs. This trend agreed well with what
was expected because electron-donating substituents, such as
methyl groups, reduce reactivity while electron withdrawing
substituents, such as halogens, increase reactivity of compounds in
the MA domain (Aptula and Roberts, 2006). It is particularly
striking that relatively small changes in the BQ structure have a
dramatic impact on the LLNA EC3. This is observed when the LLNA
EC3 decreases with increasing number of chlorine atoms added to
BQ (BQ > CBQ > DCBQ). The effect of different positions on reactivity
is observed between 2,5-DCBQ and 2,6-DCBQ in which 2,5-DCBQ
(EC3 = 0.013%) was 2.15 times more reactive than 2,6-DCBQ
(EC3 = 0.028%). This is because the para-substituted EWG inductive
influence on the leaving group is greater than the meta substituted
EWG (Mbiya et al., 2012).
The CBQ was less reactive than the DCBQ because both EWGs on
DCBQ contribute to the inductive effect vs. the effect of one EWG on
the CBQ. The other reason why DCBQs are apparently more reactive
than CBQ is because the DCBQs bind at a 1:2 ratio with protein
thiols vs. the 1:1 ratio protein thiol binding of CBQ (Mbiya et al.,
2012).
The observation that at 10% 2-MBQ is more potent than 2,5-
DMBQ is consistent with reactivity, not solubility, being the driving
force for the potency. The LLNA results demonstrated that
hydrophobicity might be an important factor in the potency
unlike in the reactivity rate model where absorption rates are not
factored in. As observed in LLNA results, ranking from extreme to
strong sensitizers seems to suggest that the rate of penetration is
increasing as the BQD become more hydrophobic (Table 1). This
ranking from extreme to strong noticed in the experiments was
absent from the predicted EC3 values demonstrating that
hydrophobicity plays a very minor role if we are to determine
EC3 values based on reactivity alone. The predictions done using
equation A1 overestimate the potency by assuming that the
penetration rates (kp) (hydrophobicity) are similar across the
whole BQD series. From the LLNA data, hydrophobicity evidently
plays a role even though reactivity was still the dominant factor.
This is demonstrated by the fact that the EC3 values for the Cl
substituted BQD classify them as extreme sensitizers and these
have higher log P values compared to Me- substituted BQD. The
large discrepancy observed between the predicted and actual
EC3 values may also be due to the fact that the potency in MA
domain is less strongly dependent on reactivity alone than other
domains. The systemic toxicity we observed with tBBQ may be a
result of increased kp such that more of the tBBQ is passing through
the skin than can be haptenated to proteins.
We previously reported the trend in the electron magnetic
resonance signal of these test chemicals to be BQ < CBQ < 2,6-
DCBQ < 2,5-DCBQ (Mbiya et al., 2012). This is the same trend
observed in the LLNA EC3 values in the present study. Taken
together with the present data we concluded that BQ radicals
potentially play a minor role in haptenation of proteins. This agrees
well with what was previously suggested by (Christensson et al.,
2006), in that semiquinone radicals may act as haptens.
6. Conclusions
The high correlation between chemical reactivity as demon-
strated empirically using the NBT assay and the LLNA threshold EC3
estimates (Table 1) of the BQ and BQD series suggests there is
potential utility of chemical reactivity for electrophilic allergen
identification and potency ranking and that the rate of chemical-
to-protein binding is a major determinant of skin allergic
sensitization potency. Influence of other physical-chemical factors
such as log P, mechanistic domain, and haptenated protein stability
on a chemical’s skin sensitization potency remains to be
determined and may vary between chemical mechanistic classes.
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Fig. 3. Correlation of pEC 3 estimated using the LLNA vs. log ka of BQ and BQD from both MA and SNV reactivity domains. pEC3 was LLNA estimates and log kawas derived from
reactivity toward NBT as previously reported (Roberts et al., 2007).
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